Tyra Biosciences
  • Our Approach
  • Pipeline & Targets
  • Our People
  • Patients
  • For Investors
Select Page
Alena Zalutskaya

Alena Zalutskaya

by amyconrad | Aug 19, 2024

Ed Slezinger

Ed Slezinger

by amyconrad | Jul 26, 2024

Marazban Sarkari

Marazban Sarkari

by amyconrad | Jul 24, 2024

Christine Yang

Christine Yang

by amyconrad | Jul 24, 2024

Rafael Cassata

Rafael Cassata

by amyconrad | Jul 22, 2024

« Older Entries
Next Entries »

Recent News

  • Tyra Biosciences raises $106M in Series B financing to advance novel pipeline of therapies targeting acquired resistance in oncology
  • Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in oncology

Categories

  • Fundraising
  • Contact
  • Terms & Conditions
  • Privacy Policy
© Copyright 2025 Tyra Biosciences, Inc. Site Design